Skip to content
  • Follow Us
CarboHyde
  • Home
  • Cyclodextrin Masterclass XIV
  • Nutraceutical Complexes
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Home
  • Cyclodextrin Masterclass XIV
  • Nutraceutical Complexes
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
CarboHyde
  • Home
  • Cyclodextrin Masterclass XIV
  • Nutraceutical Complexes
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News

Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3

Sep 28, 2022Tamas Sohajdacarbohydrates, drug discoveryanticancer, cancer research

Bathing in carbs: Lai-Xi Wang and his group from the University of Maryland reported the synthesis of cyclodextrin-based multivalent glycan ligands for human galectin-3. The GalNAc (Tn antigen) containing heptavalent ligand showed the highest affinity for human Gal-3 among the synthetic ligands tested, with an EC50 of 1.4 μM in binding to human Gal-3.

Link to the article

carbohyde, galectin, cyclodextrin


Prev
Next
Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter
  • Privacy Policy